Rankings
▼
Calendar
PHIO Q1 2019 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21,000
-8.7% YoY
Gross Profit
-$1M
-5085.7% margin
Operating Income
-$2M
-10219.0% margin
Net Income
-$2M
-10090.5% margin
EPS (Diluted)
$-617.04
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$160,000
Balance Sheet
Total Assets
$14M
Total Liabilities
$2M
Stockholders' Equity
$12M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21,000
$23,000
-8.7%
Gross Profit
-$1M
-$1M
+20.2%
Operating Income
-$2M
-$2M
+4.2%
Net Income
-$2M
-$2M
+5.4%
← FY 2019
All Quarters
Q2 2019 →